AstraZeneca’s said its COVID-19 vaccine was 76% effective in a new analysis of its U.S. trial – only a tad lower than the level in an earlier report this week criticised for using outdated data. Interim data published on Monday had put the vaccine’s efficacy rate at 79% but had not included more recent infections,...
Tag: Astrazeneca
Post
Post
The first batch of AstraZeneca vaccine arrives in Beirut
The National News Agency correspondent at Rafic Hariri International Airport stated that the first batch of AstraZeneca vaccine had arrived in Beirut.
Post
U.S. health body questions the robustness of AstraZeneca’s COVID-19 vaccine trial data
AstraZeneca Plc may have provided an incomplete view of efficacy data on its COVID-19 vaccine from a large-scale trial in the United States, a U.S. health agency said Tuesday, in a fresh setback for the shot. The concerns throw into question whether the British drugmaker can seek U.S. emergency use authorization for the vaccine in...
Post
AstraZeneca’s new trial data gives COVID-19 vaccine a boost in the U.S
AstraZeneca’s coronavirus vaccine received a major boost on Monday after data from a large trial showed it was safe and effective, potentially paving the way for its emergency authorization in the United States as countries in Asia accelerated its rollout. The trials in the United States, Chile, and Peru showed the vaccine was 79% effective...
Post
Spain, Germany, France, and Italy pause AstraZeneca vaccine rollout
Spain, Germany, France, and Italy have become the latest European countries to temporarily halt the rollout of the Oxford-AstraZeneca Covid-19 vaccine over a small number of blood clot concerns, going against the advice of international medical agencies as a third wave of infections looms over the continent. Spain will stop using the vaccine for two weeks, the...
Post
Netherlands halts use of AstraZeneca COVID-19 vaccine
The Netherlands on Sunday joined a fast-growing list of countries suspending use of AstraZeneca’s COVID-19 vaccine after reports of unexpected possible side effects from the injection. The vaccine will not be used until at least March 29 as a precaution, the Dutch government said in a statement. The announcement will lead to delays in rolling...
Post
French vaccines chief says AstraZeneca COVID vaccine shows great efficacy
French vaccination chief Alain Fischer said on Friday the AstraZeneca COVID-19 vaccine had shown great efficacy, reaffirming France’s commitment to an inoculation which has been suspended in several other countries. Speaking on Radio Classique, he also welcomed the approval by European Union health authorities of the COVID vaccine developed by Johnson & Johnson, saying it...
Post
AstraZeneca: Thailand delays vaccine rollout over blood clot fears
Thailand has delayed the rollout of the AstraZeneca’s Covid-19 vaccine over reports of blood clots, despite there being no evidence of this. The country’s prime minister was due to kick off the country’s vaccination drive by getting the jab on Friday. This has now been cancelled. The delay comes after a number of countries, including...
Post
AstraZeneca: Germany, other European countries to resume use of the vaccine
This article discusses how Germany and several other European nations decided to restart use of the AstraZeneca COVID-19 vaccine following safety reviews by health authorities.
Post
Confusion over AstraZeneca-EU talks on vaccine delay
Confusion erupted on Wednesday over a scheduled meeting between AstraZeneca and the EU to discuss the pharmaceutical group’s delay in delivering its Covid-19 vaccine. An EU official told AFP that AstraZeneca had abruptly pulled out of the meeting — the third called for this week — in what was seen as an escalation in the...